Chandrasekaran E V, Davila M, Nixon D, Mendicino J
Cancer Res. 1984 Sep;44(9):4059-68.
Two specific N-acetylglucosaminyltransferases, alpha-1,3-mannoside:beta-2-N-acetylglucosaminyltransferase (transferase I) and alpha-1,6-mannoside:beta-2-N-acetylglucosaminyltransferase (transferase II), which catalyze the transfer of N-acetylglucosamine (GlcNAc) from uridine diphospho-GlcNAc to terminal branched alpha-mannosyl (Man) residues, were purified from liver metastases of human colon adenocarcinoma. Transferase I was assayed with Man alpha 1,6(Man alpha 1,3)Man alpha 1,6(Man alpha 1,3)Man beta 1,4GlcNAc beta 1, 4GlcNAc-Asn (Km 0.35 mM), and transferase II was assayed with Man alpha 1,6(GlcNAc beta 1,2Man alpha 1,3)Man beta 1,4GlcNAc beta 1,4-Glc-NAc-Asn (Km 1.0 mM), in which Asn is asparagine. The Km of transferase I for Man alpha 1,6(Man alpha 1,3)Man beta 1,4GlcNAc-beta 1,4)-(Fuc alpha 1,6)GlcNAc-Asn was 1 mM. The specificity of the interaction of transferase I with ovalbumin, ovomucoid, the modified heavy chain of porcine immunoglobulin G and glycopeptides prepared from these glycoproteins was examined by kinetic and structural analysis. The best macromolecular substrates for transferase I were ovalbumin devoid of terminal GlcNAc and some mannose, a solubilized preparation of the heavy chain of porcine immunoglobulin G, devoid of sialic acid, galactose, and terminal GlcNAc, and untreated ovomucoid. The apparent KmS were 45, 19, and 390 microM for ovalbumin, the modified heavy chain of immunoglobulin G, and untreated ovomucoid, respectively. The apparent Km of the enzyme for uridine diphospho-GlcNAc was not significantly influenced by the nature of the glycoprotein acceptor, and it varied between 14 and 20 microM for the different glycoproteins. The structures of the oligosaccharide chains in these glycoproteins which acted as acceptors for the purified enzyme were determined. A major glycopeptide product with the structure Man alpha 1,3(Man alpha 1,6)Man alpha 1,6(14C-GlcNAc beta 1,2Man-alpha 1,3)Man beta 1,4GlcNAc-beta 1,4-GlcNAc-Asn was isolated from both ovalbumin and ovomucoid following incubation with transferase I. The specificity of the enzyme for terminal branched mannosyl residues attached to a beta-linked mannose unit greatly restricts the action of this transferase to this juncture in the synthesis of complex-type oligosaccharide chains of N-asparagine-linked glycoproteins.(ABSTRACT TRUNCATED AT 400 WORDS)
两种特定的N-乙酰葡糖胺基转移酶,即α-1,3-甘露糖苷:β-2-N-乙酰葡糖胺基转移酶(转移酶I)和α-1,6-甘露糖苷:β-2-N-乙酰葡糖胺基转移酶(转移酶II),它们催化N-乙酰葡糖胺(GlcNAc)从尿苷二磷酸-GlcNAc转移至末端分支的α-甘露糖基(Man)残基,已从人结肠腺癌肝转移灶中纯化出来。转移酶I用Manα1,6(Manα1,3)Manα1,6(Manα1,3)Manβ1,4GlcNAcβ1,4GlcNAc-Asn(Km为0.35 mM)进行测定,转移酶II用Manα1,6(GlcNAcβ1,2Manα1,3)Manβ1,4GlcNAcβ1,4-Glc-NAc-Asn(Km为1.0 mM)进行测定,其中Asn为天冬酰胺。转移酶I对Manα1,6(Manα1,3)Manβ1,4GlcNAc-β1,4)-(Fucα1,6)GlcNAc-Asn的Km为1 mM。通过动力学和结构分析研究了转移酶I与卵清蛋白、卵类粘蛋白、猪免疫球蛋白G修饰的重链以及由这些糖蛋白制备的糖肽之间相互作用的特异性。转移酶I的最佳大分子底物是不含末端GlcNAc和一些甘露糖的卵清蛋白、不含唾液酸、半乳糖和末端GlcNAc的猪免疫球蛋白G重链的可溶制剂以及未处理的卵类粘蛋白。卵清蛋白、免疫球蛋白G修饰的重链和未处理的卵类粘蛋白的表观Km分别为45、19和390 microM。该酶对尿苷二磷酸-GlcNAc的表观Km不受糖蛋白受体性质的显著影响,不同糖蛋白的表观Km在14至20 microM之间变化。确定了这些作为纯化酶受体的糖蛋白中寡糖链的结构。在与转移酶I孵育后,从卵清蛋白和卵类粘蛋白中均分离出一种主要糖肽产物,其结构为Manα1,3(Manα1,6)Manα1,6(14C-GlcNAcβ1,2Man-α1,3)Manβ1,4GlcNAc-β1,4-GlcNAc-Asn。该酶对连接在β-连接的甘露糖单元上的末端分支甘露糖基残基的特异性极大地限制了这种转移酶在N-天冬酰胺连接的糖蛋白复杂型寡糖链合成中在这一环节的作用。(摘要截短于400字)